Home
About us
Pronova BioPharma in brief
Production facilities
History
Our business concept
Vision, values and strategy
Ethical guidlines
Health, safety and environment
Human resources
Management team
Board of directors
Product
Omacor/Lovaza
Production process
Market
Distribution and partners
Research & development
Approach to R&D
R&D programs
Quality
Ensuring excellent quality
Quality Control
Quality Assurance
Audit programs
Pharmacovigilance
News
Press releases archive
Media
Media contact
Fact sheet
Fact sheet in Norwegian
Photo archive
Investors
The share
Stock market announcements
Reports and presentations
Shareholder information
Top 20 shareholders
Policies
Dividend policy
Investor relations policy
Articles of association
General meeting
Registrar
Corporate governance
Analytical coverage
Subscribe
Contact information IR
Careers
General application
What we offer
Meet some of our people
Vacancies
Contact
Contact details
Henvendelser om Omacor i Norge
You are here:
Home
/
News
Førsteklasses produksjonsresultater ga god start på 2009
Read more
Press releases
5. Feb 2010 16:15:
Presentation of fourth quarter 2009 results
8. Jan 2010 09:00:
Presentation at the SEB Investor Conference in Copenhagen
14. Dec 2009 08:15:
TAK-085 Entered into Phase 3 Clinical Programs
7. Dec 2009 08:47:
Financial calender 2010 for Pronova BioPharma ASA
25. Nov 2009 15:06:
Regulatory approval in EU achieved for the Kalundborg manufacturing plant
20. Nov 2009 14:22:
MANDITORY NOTIFICATION OF TRADE
20. Nov 2009 07:04:
Pronova BioPharma ASA presented at "Aksjedagen Norge" 2009
13. Nov 2009 15:54:
MANDITORY NOTIFICATION OF TRADE IN PRONOVA BIOPHARMA
Press releases archive
Copyright 2007
©
Pronova BioPharma ASA
idium
web publishing
